Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 μmol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal of Radiology
- Vol. 23 (3) , 205-211
- https://doi.org/10.1016/s0720-048x(96)01099-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Biodistribution and In Vivo Stability of Manganese DipyridoxylInvestigative Radiology, 1994
- Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions initial findingsClinical Imaging, 1994
- Mn‐DPDP–enhanced MR imaging of malignant liver lesions: Efficacy and safety in 20 patientsJournal of Magnetic Resonance Imaging, 1993
- Mn-DPDP in MR imaging of pancreatic adenocarcinoma: initial clinical experience.Radiology, 1993
- Mn-DPDP Enhanced MRI in Experimental Bile Duct ObstructionJournal of Computer Assisted Tomography, 1993
- Mn‐DPDP enhancement patterns of hepatocellular lesions on MR imagesJournal of Magnetic Resonance Imaging, 1993
- Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.Radiology, 1992
- Pancreatic enhancement after low-dose infusion of Mn-DPDP.Radiology, 1991
- Hepatobiliary MR imaging: first human experience with MnDPDP.Radiology, 1991
- Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.Radiology, 1991